Managing Risk Under the Physician Payment Sunshine Law and Anti-kickback Statute

is being presented by Sheva Sanders, Partner with, Leonard, Street and Deinard and airs on Wednesday, June 29th, 2011. For more details, or to register please visit our site at www.fxconferences.com

As device-related therapies have become more complex, and technological capabilities have become more sophisticated, medical device companies have expanded their activities in support of those therapies. For example, many companies provide substantial and valuable support related to stocking their products, training and education on the use of their products, reimbursement-related support, and post-implant monitoring.

At the same time, laws such as the Physician Sunshine Payment Act and the Anti-kickback Statute – focusing on the perceived conflict of interest created through the transfer of value to provider-customers – have made it critical to be able to identify reportable or prohibited transfers of value.

This audio conference presentation explores the question of whether and when the product-related support activities are reportable under the Physician Sunshine Payment Act and similar state statutes, and whether and when such activities might constitute remuneration under the federal Anti-kickback Statute and similar state statutes.